SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

OncoMed Pharmaceuticals Inc – IPO: ‘S-1/A’ on 10/24/12 – EX-23.1

On:  Wednesday, 10/24/12, at 9:46pm ET   ·   As of:  10/25/12   ·   Accession #:  1193125-12-433969   ·   File #:  333-181331

Previous ‘S-1’:  ‘S-1/A’ on 7/5/12   ·   Next:  ‘S-1/A’ on 12/3/12   ·   Latest:  ‘S-1/A’ on 7/17/13

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/25/12  OncoMed Pharmaceuticals Inc       S-1/A                  6:3.0M                                   RR Donnelley/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Amendment No. 4 to Registration Statement on Form   HTML   1.91M 
                          S-1                                                    
 2: EX-10.1(C)  Second Amendment Regarding Payment of Certain       HTML     16K 
                          Milestone Payments                                     
 3: EX-10.2(B)  Amendment 1 to the Collaboration and Option         HTML     31K 
                          Agreement                                              
 4: EX-10.20    Collaboration Agreement                             HTML     74K 
 5: EX-10.21    Multi-Product License Agreement                     HTML    131K 
 6: EX-23.1     Consent of Independent Registered Public            HTML      6K 
                          Accounting Firm                                        


EX-23.1   —   Consent of Independent Registered Public Accounting Firm


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Consent of independent registered public accounting firm  

Exhibit 23.1

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 11, 2012, in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-181331) and related Prospectus of OncoMed Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Redwood City, California

October 24, 2012


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1/A’ Filing    Date    Other Filings
Filed as of:10/25/12
Filed on:10/24/12
5/11/12S-1
 List all Filings 
Top
Filing Submission 0001193125-12-433969   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 5:18:47.1am ET